Neurotrophic factors including glial cell line-derived neurotrophic factor (GDNF) and its closely related family protein Neurturin have provided promising therapeutic effects in various animal neurotoxin models and phase I clinical trials for PD [reviewed in 207]. The gene discussed is NRTN; the disease is Parkinson disease.